208 related articles for article (PubMed ID: 21212370)
1. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission.
Chen BB; Hsu CY; Yu CW; Hou HA; Liu CY; Wei SY; Chou WC; Tien HF; Shih TT
Radiology; 2011 Mar; 258(3):821-31. PubMed ID: 21212370
[TBL] [Abstract][Full Text] [Related]
2. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
4. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
5. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy.
Griffith JF; Yeung DK; Antonio GE; Lee FK; Hong AW; Wong SY; Lau EM; Leung PC
Radiology; 2005 Sep; 236(3):945-51. PubMed ID: 16055699
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
[TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
[TBL] [Abstract][Full Text] [Related]
11. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
van Laarhoven HW; de Geus-Oei LF; Wiering B; Lok J; Rijpkema M; Kaanders JH; Krabbe PF; Ruers T; Punt CJ; van der Kogel AJ; Oyen WJ; Heerschap A
Radiology; 2005 Oct; 237(1):181-8. PubMed ID: 16183932
[TBL] [Abstract][Full Text] [Related]
12. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
[TBL] [Abstract][Full Text] [Related]
13. Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values.
Breault SR; Heye T; Bashir MR; Dale BM; Merkle EM; Reiner CS; Faridi KF; Gupta RT
AJR Am J Roentgenol; 2013 Mar; 200(3):W297-303. PubMed ID: 23436875
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
[TBL] [Abstract][Full Text] [Related]
15. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
Hillengass J; Wasser K; Delorme S; Kiessling F; Zechmann C; Benner A; Kauczor HU; Ho AD; Goldschmidt H; Moehler TM
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):475-81. PubMed ID: 17255268
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
[TBL] [Abstract][Full Text] [Related]
17. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
19. Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging.
Sourbron S; Sommer WH; Reiser MF; Zech CJ
Radiology; 2012 Jun; 263(3):874-83. PubMed ID: 22623698
[TBL] [Abstract][Full Text] [Related]
20. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
